Literature DB >> 21267340

Survey of Physicians' Attitudes to the Haemophilus Influenzae Type-b Vaccine.

D Shawn, C Gladstone, E L Ford-Jones.   

Abstract

A survey was conducted in nine centres across Canada to determine the attitudes of Canadian physicians to the recommended Haemophilus Influenzae type-b vaccine program. The questionnaire was distributed to 448 family physicians and 315 pediatricians, with response rates of 42% and 64% respectively. Only 42% of the family physicians and 57% of the primary care pediatricians expressed their intent to recommend the vaccine to all indicated patients. Their responses emphasize the need for: appropriately packaged material (in single-dose vials); government funding to ensure universal patient accessibility and to relieve physicians of an unwelcome financial burden; development of a Haemophilus influenzae type-b vaccine suitable for the major target population (i.e., children under 24 months old); and public health education. An effective Haemophilus influenzae type-b immunization program will be seen only when these goals are met.

Entities:  

Year:  1987        PMID: 21267340      PMCID: PMC2218309     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  6 in total

1.  Prevention of Hemophilus influenzae type b bacteremic infections with the capsular polysaccharide vaccine.

Authors:  H Peltola; H Käyhty; M Virtanen; P H Mäkelä
Journal:  N Engl J Med       Date:  1984-06-14       Impact factor: 91.245

2.  Immunization of US children with Hemophilus influenzae type b polysaccharide vaccine. A cost-effectiveness model of strategy assessment.

Authors:  S L Cochi; C V Broome; A W Hightower
Journal:  JAMA       Date:  1985-01-25       Impact factor: 56.272

3.  Age-related response to two Haemophilus influenzae type b vaccines.

Authors:  D J Pincus; D Morrison; C Andrews; E Lawrence; S H Sell; P F Wright
Journal:  J Pediatr       Date:  1982-02       Impact factor: 4.406

Review 4.  Newer directions in vaccine development and utilization.

Authors:  M R Hilleman
Journal:  J Infect Dis       Date:  1985-03       Impact factor: 5.226

5.  Antibody levels achieved in infants by course of Haemophilus influenzae type B polysaccharide/diphtheria toxoid conjugate vaccine.

Authors:  J Eskola; H Käyhty; H Peltola; V Karanko; P H Mäkelä; J Samuelson; L K Gordon
Journal:  Lancet       Date:  1985-05-25       Impact factor: 79.321

6.  Preparation, characterization, and immunogenicity of Haemophilus influenzae type b polysaccharide-protein conjugates.

Authors:  R Schneerson; O Barrera; A Sutton; J B Robbins
Journal:  J Exp Med       Date:  1980-08-01       Impact factor: 14.307

  6 in total
  3 in total

1.  One Flu Over the Cuckoo's Nest.

Authors:  H Seiden
Journal:  Can Fam Physician       Date:  1987-02       Impact factor: 3.275

2.  Vol au-dessus d'un nid de coucous.

Authors:  H Seiden
Journal:  Can Fam Physician       Date:  1987-03       Impact factor: 3.275

3.  Immunization delivery in British Columbia: perspectives of primary care physicians.

Authors:  John Omura; Jane Buxton; Janusz Kaczorowski; Jason Catterson; Jane Li; Andrea Derban; Paul Hasselback; Shelagh Machin; Michelle Linekin; Tamsin Morgana; Barra O'Briain; David Scheifele; Meena Dawar
Journal:  Can Fam Physician       Date:  2014-03       Impact factor: 3.275

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.